No generic substitution2
More than 80% of patients pay $0 per month for PLEGRIDY1
Biogen Copay Program
The Biogen Copay Program may lower medication cost to as little as $0 for eligible patients with commercial insurance.c
When cost may be a concern for your patients, Biogen may be able to help them start and continue on a Biogen therapy. We will work with your patients based on their individual needs.
Biogen Support Services offers a variety of different financial and insurance resources, including:
Please contact your Biogen Access & Reimbursement Manager (ARM) for more information on these resources or call Biogen Support Services at 1-800-456-2255 if you have any questions or concerns about patient access to PLEGRIDY.
a Formulary status alone does not imply comparison of safety, efficacy, or dosage regimens of products for relapsing MS.
b Based on Breakaway Partners, Drug Coverage Analytics, March 12, 2020. Biogen does not endorse any particular plan. Because formularies change and many health plans offer more than 1 formulary, it is important to check directly with the health plan to confirm coverage for individual patients.
c There is an annual cap on the amount of assistance that patients can receive over a one-year period. Federal and state laws and other factors may prevent or otherwise restrict eligibility. People covered by Medicare, Medicaid, the VA/DoD, or any other federal plans are not eligible to enroll. Patients are eligible to enroll in the Biogen Copay Program for as long as it is offered and they are treated with a Biogen relapsing MS medication.